Jl (Glutamic Acid)

Glutamic acid participates in protein building, acts as a key excitatory neurotransmitter, and contributes to nitrogen transport and energy metabolism. By serving as a substrate for other amino acids and neurotransmitters, it helps maintain normal cellular functions and metabolic processes.

The appropriate dose of Jl is determined by a qualified prescriber based on the individual’s health status, age, and nutritional needs. Patients should follow the specific dosing instructions provided by their healthcare professional.

Safety data for glutamic acid supplementation during pregnancy or lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before starting Jl to assess potential risks and benefits.

To order Jl, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Jl provides glutamic acid, a specific non‑essential amino acid, whereas many other supplements contain a blend of essential amino acids or protein hydrolysates. Glutamic acid’s unique role as a neurotransmitter precursor and its involvement in nitrogen metabolism differentiate it from broader protein or BCAA products.

Jl should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Jl is taken orally, typically as a powder, capsule, or tablet, depending on the supplied form. The product should be consumed with water or as directed by a healthcare professional, following the prescribed dosage schedule.

Serious risks, though rare, include allergic reactions such as rash, itching, or swelling, and neurological hyperexcitability that may lead to seizures in susceptible individuals. Patients with severe kidney impairment should be monitored closely for potential renal overload.

Individuals with known hypersensitivity to glutamic acid, those experiencing severe renal or hepatic impairment without medical supervision, and patients taking medications that may interact significantly (e.g., certain antiepileptics, MAO inhibitors, or lithium) should avoid using Jl unless advised otherwise by a qualified healthcare provider.